IgG4-related disease: 2013 update

被引:8
作者
Monach P.A. [1 ]
机构
[1] Vasculitis Center, Section of Rheumatology, Boston University School of Medicine, Boston, MA 02118, 72 East Concord Street
关键词
Aortitis; Autoimmune pancreatitis; IgG4-Related disease; Periaortitis; Retroperitoneal fibrosis;
D O I
10.1007/s11936-013-0232-y
中图分类号
学科分类号
摘要
Opinion statement: Having diagnosed a patient as having IgG4-related disease, I would have a low threshold for recommending immune-suppressive treatment, and would make that recommendation for any patient with vascular involvement. My initial approach would be prednisone at 40-60 mg/day with a plan to reduce the dose every two weeks, e.g., 40, 30, 20, 15, 10, 7.5, 5, and 2.5 mg for 2 weeks each. In the event of relapse, I would double the current prednisone dose, slow the taper, and add azathioprine, anticipating using that drug for one year if the patient were to remain in remission. In the event or subsequent relapse, I would stop azathioprine and use rituximab. In a patient with large artery involvement, I would consult a vascular surgeon soon after diagnosis, anticipating a need for surgical repair. © 2013 Springer Science+Business Media New York.
引用
收藏
页码:214 / 223
页数:9
相关论文
共 63 条
  • [1] Stone J.H., Khosroshahi A., Deshpande V., Chan J.K., Heathcote J.G., Aalberse R., Et al., Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations, Arthritis Rheum, 64, pp. 3061-3067, (2012)
  • [2] Sakamoto A., Nagai R., Saito K., Imai Y., Takahashi M., Hosoya Y., Et al., Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis-retrospective analysis of 11 case histories, J Cardiol, 59, pp. 139-146, (2012)
  • [3] Omura Y., Yoshioka K., Tsukamoto Y., Maeda I., Morikawa T., Konishi Y., Et al., Multifocal fibrosclerosis combined with idiopathic retro-peritoneal and pericardial fibrosis, Intern Med, 45, pp. 461-464, (2006)
  • [4] Sugimoto T., Morita Y., Isshiki K., Yamamoto T., Uzu T., Kashiwagi A., Et al., Constrictive pericarditis as an emerging manifestation of hyper-IgG4 disease, Int J Cardiol, 130, (2008)
  • [5] Stone J.R., Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease, Curr Opin Rheumatol, 23, pp. 88-94, (2011)
  • [6] Zen Y., Kasashima S., Inoue D., Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease, Semin Diagn Pathol, 29, pp. 212-218, (2012)
  • [7] Kasashima S., Zen Y., IgG4-related inflammatory abdominal aortic aneurysm, Curr Opin Rheumatol, 23, pp. 18-23, (2011)
  • [8] Stone J.H., Khosroshahi A., Deshpande V., Stone J.R., IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases, Arthritis Care Res (Hoboken), 62, pp. 316-322, (2010)
  • [9] Ishizaka N., Sakamoto A., Imai Y., Terasaki F., Nagai R., Multifocal fibrosclerosis and IgG4-related disease involving the cardiovascular system, J Cardiol, 59, pp. 132-138, (2012)
  • [10] Zen Y., Nakanuma Y., IgG4-related disease: A cross-sectional study of 114 cases, Am J Surg Pathol, 34, pp. 1812-1819, (2010)